Apolipoprotein E phenotype is not related to late-life depression in a population-based sample

Social Psychiatry and Psychiatric Epidemiology

Volumn 33, Issue 1, 1997, Pages 21-26

  Schmand, B ^a,b   Hooijer, C ^a,c   Jonker, C ^a   Lindeboom, J ^a   Havekes, L M ^d  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c Van Foreest Centrum   (Netherlands)

^d TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; DEMENTIA; FAMILY HISTORY; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE;

EID: 0031938664     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001270050017     Document Type: Article

References (50)

1. Altman DG (1991) Practical statistics for medical research. Chapman and Hall, London
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders 3rd revised edn, DSM-III-R. APA, Washington D.C.
3. Benjamin R, Leake A, McArthur FK, Ince PG, Candy JM, Edwardson JA, Morris CM, Bjertness E (1994a) Protective effect of ApoE ε2 in Alzheimer's disease. Lancet 344: 473
4. Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH, Morris CM (1994b) Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 343: 1565
5. Copeland JRM, Kelleher MJ, Kellett JM, Gourlay AJ, Gurland BJ, Fleiss JL, Sharpe L (1976) A semistructured clinical interview for the assessment of diagnosis and mental state in the elderly the Geriatric Mental State Schedule. I. Development and reliability. Psychol Med 6: 439-449
6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
7. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pencak-Vance MA (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat Genet 7: 180-184
8. Davignon J, Gregg RE, Sing CG (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-12
9. Dewey ME, Copeland JRM (1986) Computerised psychiatric diagnosis in the elderly: AGECAT. J Microcomput Appl 9: 135-140
10. Fillenbaum GG, George LK, Blazer DG (1988) Scoring nonresponse on the Mini-Mental State Examination. Psychol Med 18: 1021-1025
11. Folstein MF, Folstein S, McHugh PR (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198
12. Frisoni GB, Geroldi C, Bianchetti A, Trabucchi M, Govoni S, Franceschini G, Calabresi L (1994) Apolipoprotein E ε4 allele frequency in vascular dementia and Alzheimer's disease. Stroke 25: 1703-1704
13. Haberman SJ (1978) Analysis of quantitative data, vol. 1. Introduction topics. Academic Press, New York
14. Haeenaars JA (1990) Categorical longitudinal data. Log-linear panel trend and cohort analysis. Sage Publications, London
15. Havekes L, De Knijff P, Beiseigel U, Havinga J, Smit M, Klasen E (1987) A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res 28: 445-463
16. Hooijer C, Dinkareve M, Jonker C, Lindeboom J (1992) Short screening tests for dementia in the elderly population. I. A comparison between AMTS, MMSE, MSQ and SPMSQ. Int J Geriatr Psychiatry 7: 559-571
17. Jorm AF, Van Duijn CM, Chandra C, Fratighoni L, Graves AB, Heyman A, Kokmen E, Kondo K, Mortimer JA, Rocca WA, et al (1991) Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20 [Suppl 2]: S43-S47
18. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J (1994) Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 57: 1414-1416
19. Koller WC, Glatt SL, Hubble JP, Paolo A, Tröster AI, Handler MS, Horvat RT, Martin C, Schmidt K, Karst A, Wijsman EM, Yu C-E, Schellenberg GD (1995) Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol 37: 242-245
20. Launer LJ, Dinkgreve MAHM, Jonker C, Hooijer C, Lindeboom J (1993) Are age and education independent correlates of the Mini-Mental State Exam performance of community-dwelling elderly? J Gerontol Psychol Sci 48: P271-P277
21. Launer LJ, Wind AW, Deeg DJH (1994) Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly. Am J Epidemiol 139: 803-812
22. Launer LJ, Scheltens PH, Lindeboom J, Barkhol F, Weinstein HC, Jonker C (1995) Medial temporal lobe atrophy in an open population of very old persons: cognitive, brain atrophy, and sociomedical correlates. Neurology 45: 747-752
23. Lippa CF, Smith TW, Saunders AM, Crook R, Pulaski-Salo D, Hardy J, Roses AD, Dickson D (1995) Apolipoprotein E genotype and Lewv body disease. Neurology 45: 97-103
24. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 62-630
25. Marder K, Maestre G, Cote L, Mejia H, Alfaro B, Halim A, Tang M, Tycko B, Mayeux R (1994) The apolipoprotein ε4 allele in Parkinson's disease with and without dementia. Neurology 44: 1330-1331
26. Menzel H-J, Kladetzky R-G, Assmann G (1983) Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 3: 310-315.
27. Migliorelli R, Tesón A, Sabe L, Petracchi M, Leiguarda R, Starkstein SE (1995) Prevalence and correlates of dysthymia and depression among patients with Alzheimer's disease. Am J Psychiatry 152: 37-44
28. Mutamatsu T, Higuchi S, Arai H, Sasaki H, Yamada K, Hayashida M, Trojamowski J (1994) Apolipoprotein E ε4 allele distribution in alcoholic dementia and in Alzheimer's disease in Japan. Ann Neurol 36: 797-799
29. National Institute on Aging, Alzheimer's disease Association Workina Group (1996) Apolipoprotein E genotyping in Alzheimer's disease. Lancet 347: 1091-1095
30. Noguchi S, Murakami K, Yamada N (1993) Apolipoprotein E genotype and Alzheimer's disease. Lancet 342: 737
31. Pedro-Botet J, Senti M, Nogues X, Rubies-Prat J, Roquer J, D'Olhaberriague L, Olive J (1992) Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 23: 1556-1562
32. Pickering-Brown SM, Mann DMA, Bourke JP, Roberts DA, Balderson D, Burns A, Byrne J, Owen F (1994) Apolipoprotein E and Alzheimer's disease pathology in Lewy body disease and in other β-amyloid-forming diseases. Lancet 343: 1155
33. Plassman BL, Breitner JCS (1996) Apolipoprotein E and cognitive decline in Alzheimer's disease. Neurology 47: 317-320
34. Roses AD (1995) Apolipoprotein E genotyping in the differential diagnosis, not prediction of Alzheimer's disease. Ann Neurol 38: 6-14
35. Roth M, Huppert FA, Tym E, Mountjoy CQ (1988) CAMDEX: the Cambridge examination for mental disorders of the elderly. Cambridge University Press, Cambridge
36. Rubinsztein DC (1995) Apolipoprotein E: a review of its role in lipoprotein metabolism, neuronal growth, and repair and as a risk factor for Alzheimer's disease. Psychol Med 25: 223-229
37. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Helette C, Crain B, Goldbager D, Roses AD (1993) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472
38. Schmand B, Jonker C, Hooijer C, Lindeboom J (1996) Subjective memory complaints may announce dementia. Neurology 46: 121-125
39. Schmand B, Jonker C, Geerlings MI, Lindeboom J (1997) Subjective memory complaints in the elderly. Relation with depressive symptoms and future dementia. Br J Psychiatry (in press)
40. Seshadri S, Drachman DA, Lippa CF (1995) Apolipoprotein E ε4 allele and the lifetime risk of Alzheimer's disease. Arch Neurology 52: 1074-1079
41. Smit M, de Knijff P, Rosseneu M, Bury J, Klasen EC, Frants RR, Havekes LM (1988) Apolipoprotein E polymorphism in The Netherlands, and its effect on plasmalipid and apolipoprotein levels. Hum Genet 80: 287-292
42. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance MA, Enghild J, Salvesen GS (1993) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 90: 1977-1981
43. Tabaton M, Rolleri M, Masturzo P, Cammarata S, Angelini G, Hansen LA, Saitoh T, Petersen RB, Perry G, Richey P, Gambetti P, Bertolini S (1995) Apolipoprotein E ε4 allele frequency is not increased in progressive supranuclear palsy. Neurology 45: 1764-1765
44. Thilmann P, Ernst C, Czech C, Kaumeier S, Beyreuther K, Förstl H (1996) Low Apolipoprotein E4 allelic frequency in Alzheimer's disease and functional psychiatric disorders. Dementia 7: 118-119
45. Van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, van Broeckhoven C (1994) Apolipoprotein ε4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 7: 74-78
46. Van Gool WA, Evenhuis HM, van Duijn CM (1995) A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Aging. Ann Neurol 38: 225-230
47. Van Ojen R, Hooijer C, Bezemer D, Jonker C, Lindeboom J, van Tilburg W (1995a) Late-life depressive disorder in the community. I. The relationship between MMSE score and depression in subjects with and without psychiatric history. Br J Psychiatry 166: 311-315
48. Van Ojen R, Hooijer C, Bezemer D, Jonker C, Lindeboom J, van Tilburg W (1995b) Late-life depressive disorder in the community. II. The relationship between psychiatric history, MMSE score and familial determinants of depression. Br J Psychiatry 166: 316-319
49. Van Ojen R, Hooijer C, Bezemer D, Jonker C, Lindeboom J, van Tilburg W (1995c) Late-life depressive disorder in the community: early onset and the decrease of vulnerability with increasing age. J Affect Disord 33: 159-166
50. Waring SC, O'Brien PC, Kurland LT, Thibodeau SN, Tsai M-C, Petersen RC, Esteban-Santillan CE (1994) Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/Parkinsonism-dementia complex. Lancet 343: 611